Last reviewed · How we verify
Colloidal Oatmeal Cream
Colloidal Oatmeal Cream is a Topical emollient and skin protectant Small molecule drug developed by Johnson & Johnson Consumer and Personal Products Worldwide. It is currently FDA-approved for Dry skin and itching, Eczema and atopic dermatitis, Psoriasis. Also known as: Not yet marketed.
Colloidal oatmeal forms a protective barrier on the skin and provides anti-inflammatory and emollient properties to soothe irritated skin.
Colloidal Oatmeal Cream is a topical lotion used in clinical trials to assess its effects on the skin microbiome and associations with itch, particularly in relation to atopic dermatitis. The exact mechanism of Colloidal Oatmeal Cream is unknown, as per ChEMBL database.
At a glance
| Generic name | Colloidal Oatmeal Cream |
|---|---|
| Also known as | Not yet marketed |
| Sponsor | Johnson & Johnson Consumer and Personal Products Worldwide |
| Drug class | Topical emollient and skin protectant |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | FDA-approved |
Mechanism of action
Colloidal oatmeal consists of finely ground oat kernels that disperse in water to create a colloidal suspension. When applied topically, it adheres to the skin surface, forming an occlusive layer that reduces transepidermal water loss and traps moisture. The oatmeal contains beta-glucans and avenanthramides, which possess anti-inflammatory and antioxidant properties that help reduce skin irritation and itching.
Approved indications
- Dry skin and itching
- Eczema and atopic dermatitis
- Psoriasis
- General skin irritation and inflammation
Common side effects
- Local skin irritation
- Allergic contact dermatitis
- Rash
Key clinical trials
- Bodewell Products for the Treatment of Atopic Dermatitis (PHASE4)
- Metabolomics Initiative: Mediterranean-amplified vs Habitual Western Diet on Food Signatures, Health, and Microbiome (NA)
- Colloidal Oatmeal, Colloid Cream, Diaper Rash, Preterm Neonates and Neonatal Intensive Care Unit (PHASE4)
- Pilot Study to Test the Effects of Arctiva on Mild to Moderate Eczema (NA)
- Nutritional Biomarker Screening for Defined Food Groups (NA)
- The Effect of a Breakfast Meal Containing Oat β-glucan on Food Intake at a Subsequent Meal in Normal-weight and Overweight Subjects (NA)
- Clinical Trial to Assess the Effects of Topical Lotions on Changes in the Skin Microbiome and Associations With Itch (NA)
- Glycemic and Insulinemic Impact of Oats With Additional Dried Fruits, Nuts and Seeds Soaked Overnight (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Colloidal Oatmeal Cream CI brief — competitive landscape report
- Colloidal Oatmeal Cream updates RSS · CI watch RSS
- Johnson & Johnson Consumer and Personal Products Worldwide portfolio CI
Frequently asked questions about Colloidal Oatmeal Cream
What is Colloidal Oatmeal Cream?
How does Colloidal Oatmeal Cream work?
What is Colloidal Oatmeal Cream used for?
Who makes Colloidal Oatmeal Cream?
Is Colloidal Oatmeal Cream also known as anything else?
What drug class is Colloidal Oatmeal Cream in?
What development phase is Colloidal Oatmeal Cream in?
What are the side effects of Colloidal Oatmeal Cream?
Related
- Drug class: All Topical emollient and skin protectant drugs
- Manufacturer: Johnson & Johnson Consumer and Personal Products Worldwide — full pipeline
- Therapeutic area: All drugs in Dermatology
- Indication: Drugs for Dry skin and itching
- Indication: Drugs for Eczema and atopic dermatitis
- Indication: Drugs for Psoriasis
- Also known as: Not yet marketed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing